Malignant neoplasm of skin, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient at the clinical ambulatory of Dermatology of the Hospital das Cínicas da FMB-Unesp with diagnosis of low-risk basal cell carcinoma; clinically evident of up to 10mm in diameter; Sign the informed consent form.
Exclusion criteria
Exclusion criteria: Injury from previous basal cell carcinoma recurrence; Gestation; breastfeeding; Not concordant; Coagulation disorder; Immunosuppression; Difficulty maintaining adequate local care; Difficulty of understanding; Inability to attend outpatient visits.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare rates of local recurrence in the treatment of low risk basal cell carcinoma by curettage and electrocoagulation or excision and suture in 1 OR 2 years of follow-up through clinical and dermoscopic evaluation at the procedure site. We will compare the variation in recurrence between treatment methods.;Assess patient satisfaction with the procedure after 3 months of the intervention using a questionnaire that measures satisfaction with the procedure performed. There is no statistical difference in the degree of satisfaction between the methods. | — |
Secondary
| Measure | Time frame |
|---|---|
| Identify surgical complications such as infection, dehiscence, significant bleeding, intensity of local pain, pruritus and scar retraction, questioning the patient retrograde in the three month post-intervention reassessment. There is no statistical significance between the two methods.;Analyze the aesthetic aspect of the scar using a scar assessment scale performed by the observer and the patient three months after the intervention. There is no statistical significance between the two methods. | — |
Countries
Brazil
Contacts
Faculdade de Medicina de Botucatu